Using the no-pay list to control costs

Medicare is wading into dangerous territory here. Instead of further scrutinizing the current conditions on the no-pay list, they’re aggressively expanding it.

Policy makers should be aware of the unintended consequences of certain pay for performance measures.

A poorly thought-out no-pay list will lead to similar circumstances, paradoxically increasing costs and patient harm:

For example, even with the best treatment, blood clots remain relatively common in patients after knee and hip replacements, according to the Society of Hospital Medicine, a national group of hospital-based docs. What’s more, the new rules could add incentives for hospitals to over-use blood thinners in an effort to drive rates down.

View 1 Comments >

Most Popular

Join 150,000+ subscribers

Get the best of KevinMD in your inbox

Sign me up! It's free. 
✓ Join 150,000+ subscribers 
✓ Get KevinMD's 5 most popular stories
Subscribe. It's free.